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Supplementary Results 70
For statistical robustness, we excluded the genetic variants appearing as a singleton in 71 our dataset. Therefore, in addition to the polymorphic sites that are identified associated with 72 pathogenicity by Cox proportional hazard model, we also investigated the structural and 73 functional importance of all observed variants in the proteome of avian H1N1 IAVs. We also 74 manually checked the genomes of avian H1N1 IAVs for the presence of previously known 75 adaptation, virulence, transmission, and drug resistance markers, as well as the antigenic 76 similarities between avian and pandemic H1N1 IAVs. 77
78
Polymerase proteins 79
We identified 12 variants in the cap-binding domain of PB2 (residues 318-483) 80
( Supplementary Fig. S12a ), six of which (V338I, R340K, E342D, R355K, V356I, and E358V) 81
were clustered within 10 Å of m 7 GTP (pre-mRNA cap analog) binding ( Supplementary Fig.  82 S12b). Interestingly, none of those six variants was observed in low-pathogenic strains (survival 83 score ≥ 0.457, Supplementary Table 1 ). Variants surrounding m 7 GTP are not anticipated to 84 drastically affect protein stability or solubility, because they were of similar physicochemical 85 properties, surface exposed, and did not directly interact with the m 7 GTP. However, their 86 positions in the structure indicated that they could slightly perturb and influence residues that 87 line the m 7 GTP-binding pocket. Four of the 10 most pathogenic strains 88 (A/mallard/ALB/119/1998, A/mallard/MN/AI07-3100/2007, A/mallard/ALB/201/1998, and 89 A/mallard/ALB/88/2004) ( Supplementary Table S1 ) contain variants in their cap-binding 90 domains at their methyl guanylyltransferase (MGT)-binding pocket. Additionally, all viruses with 91 the variants in the cap-binding domain belong to avian IAVs of the Anseriformes origin. 92
Previously, it was shown that arginine and lysine variants at residue 355 at the cap-binding 93 domain of PB2 are related to high pathogenicity of H5N1 IAVs in mice models, and Q355 is 94 associated with low pathogenicity [1] [2] [3] . Therefore, the arginine or lysine variants at residue 355 of 95 31 avian H1N1 viruses may increase the virulence of the viruses in mice, although we cannot 96 support this notion statistically due to the lack of statistical power (K355; n=1 and R355; n=30) 97 variants in our sample set ( Supplementary Fig. S1 ). 98
We detected six variants in the host-specific domain of PB2 (538-678 aa) of avian 99 H1N1 viruses: four were surface exposed (D567A, G590S, V649I, and K660R), and two were 100 buried (I553V and V667I). The variant V649I was identified in relation to increased pathogenicity 101 in mice by residue effect using Cox proportional hazard model ( Supplementary Table S2 ). 102
Amino acid substitutions at residue 627 (glutamic acid to lysine) and 701 (aspartic acid to 103 asparagine) are important in terms of mammalian adaptation of an avian virus 4,5 . All 31 North 104
American avian H1N1 viruses carry avian-like E627 and D701 at those sites. However, the PB2 105 protein of the 2009 pandemic H1N1 did not acquire the E627K or D701N mutation. Instead, the 106 acquisition of mutations at other sites, such as G590S and Q591R (SR polymorphism), have 107 been identified as compensatory of E627K substitution that enhances the viral replication and 108 polymerase activity in mammalian cells 6,7 . In our dataset of 31 avian H1N1 IAVs, we observed 109 the avian-like GQ motif at positions 590-591 of PB2 in 27 viruses; however, we detected SQ Supplementary Fig. S3 ). The latter two viruses were among the low pathogenic viruses with 120 survival scores 0.457 and 0.571, respectively ( Supplementary Table S1 ). So, S66 in the PB1-121 F2 of avian H1N1 IAVs might explain the increased virulence of most of the viruses in the 122 mouse model. 123
Using the available crystal structures of PA, we structurally investigated the variants for 124 importance, with the majority of variants (26 of 33) being detected in the C-terminal PA-PB1-125 binding site (Supplementary Figs. S4, S13). Most of the residues were present on the protein 126 surface, and seven variants (V323I, P332S, A337T, V542I, L543I, I545V, and V565I) clustered 127 within 10Å of each other ( Supplementary Fig. S13a ). Variants V323I and I545V in PA coevolved 128 in most of the viruses, and given their location in the core of the protein might compensate for 129 each other to stabilize the molecule (Table 2 and Supplementary Fig. 13a ). Human-like 130 signatures D382 and N409 were observed in several avian H1N1 IAVs 9 . Among the 31 avian 131 increased length of N409 might interact weakly with PB1, which would not occur with the 136 smaller S409 ( Supplementary Fig. S13b ). Therefore, S409N might provide an additional 137 stabilizing contact between PA and PB1. Overall, five of the six avian H1N1 viruses of 138 Charadriiformes origin had one or the other human-like residue in their PA that might increase 139 their pathogenicity in mammalian models. 140
Seven variants were detected in the N-terminal endonuclease domain of PA (residues 1-141 197) ( Supplementary Fig. S4 ). None of the variants were located directly in the catalytic site, but 142 two were adjacent (I118V and T162I). Structurally, these variants were anticipated to affect the 143 stability of the secondary shell, but they did not appear to drastically disrupt the orientation of 144 residues lining the binding pocket ( Supplementary Fig. S14 ). 145 146
Surface glycoproteins 147
Avian H1N1 IAVs have seven conserved glycosylation sites at residues 22, 23, 40, 104, 148 304, 498, and 557 in their HA. It is not clear whether the viruses use both glycosylation sites at 149 residues 22 and 23, or if residue 23 is only used alternatively. Using the available crystal 150 structures, we modeled 40 variants: 32 in the head domain and eight in the stalk domain 151 ( Supplementary Fig. S15a ). Ten of the 25 variants in the globular head (residues 59-292) were 152 observed at antigenic sites, and 15 were at nonantigenic sites. All H1N1 viruses isolated from 153
Charadriiformes displayed four variants (E132Q, A137S, T169I, and K236Q) that co-occurred. 154
The T169I substitution was also observed in eight viruses of Anseriformes origin. Four of the 25 155 variants in the globular head were in the receptor-binding site (I168L, T169I, L208I, and I266V) 156
( Supplementary Fig. S15b ). Residues 169, 208, and 266 would influence carbohydrate 157 interactions, and residue 168 would influence residues on the surface of the Sa antigenic site. 158
The T169I variant is the only one seen in almost half of the viruses. The side chain faces the 159 binding site altering carbohydrate-protein interactions. 160
We determined the distribution of the variants at the antigenic sites ( Supplementary Fig.  161 S16) for several selected viruses from the most pathogenic group in DBA/2J mice. Eleven of the 162 variants at the nonantigenic sites (60, 132, 137, 138, 169, 188, 213, 228, 236, 279, and 286) 163 were surface exposed, and four (125, 168, 266, and 289) were buried. We did not observe a 164 defined pattern in the distribution of the variants at nonantigenic sites of the H1N1 viruses of 165
Anseriformes origin. However, we observed localized and enriched variants at the nonantigenic 166 sites of H1N1 viruses of Charadriiformes origin ( Supplementary Fig. S16f ). 167
We examined the residues at the HA antigenic sites based on the variations observed 168 between human H1N1 IAVs throughout the years and pandemic H1N1 viruses (1918 and 2009) 169 10 and compared those with avian H1N1 IAVs. Of the 50 residues found at the antigenic sites of 170 HA (Sa, Sb, Ca, and Cb), 21 residues appeared to be conserved among human, avian, and 171 pandemic H1N1 IAVs. North American avian H1N1 IAVs were similar to both 1918 and 2009 172 pandemic viruses at 13 residues (K170, G172, S174, and K177 in Sa; G187 in Ca; T201, Q206, 173 S207, L208, Q210, and N211 in Sb; and T89 and A90 in Cb), while human H1N1 viruses 174 showed variations throughout the years. We observed similarities to either pandemic virus at 175 some other positions. For instance, avian H1N1 IAVs carry five additional residues identical to 176 those in the 1918 virus (Y155, S159, N185, and K222 in Ca; and L88 in Cb) but not those in 177 human H1N1 or 2009 pandemic virus. Similarly, these viruses carry residues identical to those 178 of the 2009 pandemic virus (N173 in the Sa antigenic site in H1N1 IAVs of Anseriformes and 179
Charadriiformes origin, and P154 in the Ca antigenic site only in H1N1 IAVs of Charadriiformes 180 origin). On the basis of 10 polymorphic residues identified at the HA antigenic sites of avian 181 H1N1 IAVs, we did not observe any significant difference between H1N1 viruses of 182
Anseriformes and Charadriiformes origin in terms of their antigenic similarity to either pandemic 183 virus ( Supplementary Table S5 ). 184
Seven glycosylation sites were detected in the NA protein of North American avian 185 H1N1 viruses at residues 50, 58, 63, 68, 88, 146, and 235. Six of these were observed in all 31 186 Five of the polymorphic sites (260, 262, 416, 449, and 450) were surface exposed and observed 189 near the interface between monomers ( Supplementary Fig. S17b ). 190
The effect of the variants on oligomerization was most likely small due to the variable coordinates Ca +2 binding ( Supplementary Fig. S17c ) which is important for stabilizing the NA 193 protein 11 . Residues in position 386 help coordinate Ca +2 via backbone interactions, indicating 194 that small changes in the side chain can be tolerated. One avian H1N1 virus, 195 A/pintail/ALB/210/2002, contained the R430K variant. This variant was not a drastic electrostatic 196 or stereochemical change, but it does occur adjacent to the residues on the "150 loop", which 197 forms a cavity adjacent to the catalytic pocket and is being explored as a target for antiviral 198 inhibitors 11,12 . All the other variants (surface-exposed or buried) were similar in their 199 physiochemical changes and did not appear to affect the function of the protein. We identified 200 three variable sites (220, 221, and 430) surrounding the active site; however, none of those 201 positions were directly involved in the formation of the active-site pocket. 202
All 31 North American avian H1N1 viruses in our study displayed H275 (274 in N2 203 numbering) and N295 (294 in N2 numbering); therefore, these residues are probably sensitive 204 to NA inhibitors. Stalk deletion in NA is known to facilitate the adaptation of avian IAVs to 205 mammals. However, we did not detect deletion in the NA stalk of avian H1N1 IAVs. 206 207 Nucleoprotein 208
We detected 22 polymorphic sites in the NP-coding region ( Supplementary Fig. S7 ). Of 209 those, only two (143 and 478) were associated with decreased pathogenicity in two H1N1 210 viruses of Anseriformes origin after adjusting the residue effect (adjusted P (FDR) = 9.50E-03; 211 Supplementary Table S3 ). 212
The NP protein contains a perpendicular helix that divides the protein into two regions, 213 the head and body. RNA is thought to bind along the perpendicular helix of NP (Supplementary 214 slightly, which might affect the stability of the helix and RNA binding. The variant S478P is 219 surface exposed and present at the C terminus of the protein (data not shown). 220 221
Matrix and nonstructural proteins 222
The variants in M1 (S70N and N85D) were not located on the nuclear-localization signal 223 (residues 101-105) or on the NEP-interaction interface. Both were solvent exposed, and their 224 effect on function is unknown. V27A, A30S, and S31N substitutions were previously described 225 as amantadine resistance markers in M2 13 . None of the 31 North American avian H1N1 viruses 226 in our study contained these markers; therefore, they are predicted to be sensitive to 227
amantadine. 228
In terms of the structural and functional importance of each substitution in NS1 on the 229 pathogenicity of viruses, our main focus was on the effector domain (residues 74-230), because 230 it affects various key functions by binding the host cell's proteins 12 . Key variants were identified 231 at the PDZ-ligand motif, the nuclear-export signal, and the dimer interface. On the basis of 232 interface interactions between NS1 and PI3K domain, we identified six interactions (Y89, R96, 233 S99, D101, R118, and E159) that participate in hydrogen-bond interactions with the PI3K-234 inhibitory domain ( Supplementary Fig. S19a ), two of which (D101E and R118K) were present in 235 all pathogenic viruses. Six of the remaining 11 hydrophobic interactions were observed variants 236 in avian H1N1 IAVs (S87, L95, M98, I145, L146, and S161). The variant R118K might allow 237 closer packing of the PI3K helix to the NS1 protein (Table 2 and Supplementary Fig. S18 ) 238
possibly by a decrease in the steric size at residue 118 due to the arginine-to-lysine substitution. 239
We observed E227G substitution in NS1 of three pathogenic H1N1 IAVs of 240
Charadriiformes origin. We then assessed all 195 full-length NS1 sequences with a GSEV motif 241 that were on the NCBI Influenza Virus Resources database to identify the hosts and virus 242 subtypes in which the GSEV motifs were located at the 3' end of the ORF. Of the NS1 243 sequences with a GSEV motif, 78.5% were detected in avian IAVs; 35.9% belonged to the 244 H5N1 subtype ( Supplementary Table S6 ); and 29.4% were isolated from highly pathogenic 245 avian H5N1 viruses. The circulation of a GSEV PDZ-binding domain in IAVs of various regions 246 and hosts over the years ( Supplementary Table S7 ) allows us to speculate that the GSEV motif 247 appeared in the early 1980s in Eurasian swine with transitory occurrence in avian subtypes 248 through the years until 2006. That year, GSEV was acquired mainly by Charadriiformes from 249
Eurasia and North America, as well as by a Eurasian H5N1 virus that was highly pathogenic. In Variants observed in NS1 (magenta) and those in NS1 that are discussed in the text (red -sticks 378 and text) are labeled. Variants in PI3K are indicated in black text, and interactions between the 379 residues are indicated in black-dotted lines. These positions were based on the sequences used 380 in this study. 381 Supplementary Table S1 Note: The sites 75 in PB1-F2, 7 in NS1 and 7 in NEP have multiple residue variations associated with pathogenicity.
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